METHODS: This series includes 6 consecutive patients with symptomatic severe mitral annular calcification deemed to be at high risk for standard surgery. All patients underwent direct transatrial implantation of balloon-expandable SAPIEN valve in the mitral position.
INTRODUCTION
Mitral annular calcification (MAC) is caused by progressive degeneration of the mitral annulus, which can lead to valvular obstruction and/or regurgitation [1, 2] . Severe MAC presents significant technical challenge during conventional mitral valve (MV) replacement (MVR) and is associated with significant morbidity and high mortality [3] .
Transcatheter MV implantation has emerged as a therapeutic option for high-risk patients with severe MAC [4] . Challenges with transcatheter MV implantation include anchoring and seating of the valve prosthesis as well as left ventricular outflow tract (LVOT) obstruction. Direct transatrial implantation of the prosthesis has the potential advantages of direct visualization, concomitant resection of the anterior leaflet to lower the risk of LVOT obstruction, better alignment of the prosthesis in relation to the mitral annulus and the potential for surgical management of possible complications that may occur with the implantation. We present our early experience with this method, which was performed in 6 consecutive patients with severe MAC.
METHODS
This retrospective case series includes 6 consecutive patients who underwent direct transatrial MV implantation using the SAPIEN 3 valve (Edwards Lifesciences, Irvine, CA, USA) and SAPIEN XT (Edwards Lifesciences). All procedures were performed at Mayo Clinic in Rochester, MN, USA, from December 2014 till May 2016.
Procedural inclusion criteria included the presence of severe calcific MV stenosis with or without concomitant regurgitation †Presented at the Annual Meeting of the Transcatheter Cardiovascular Therapeutics, Washington, DC, USA, 29 October 2016. that was considered amenable to valve in native valve placement of an appropriately sized balloon-expandable prosthesis. All patients were deemed to be of higher risk for standard MVR. Patients were presented with various management options including medical therapy, surgery or transcatheter valve replacement, with the knowledge that it would be off-label use of the balloon-expandable valve. Informed consent was obtained from all patients. Institutional review board approval was obtained for this case series.
Procedure
Procedures were jointly planned by clinicians from interventional cardiology, echocardiography, cardiovascular surgery and anaesthesiology. Multimodality imaging, including transthoracic, transoesophageal echocardiography and cardiac computed tomography (CT) angiography, was used to evaluate the anatomy and size the valves.
Retrospective electrocardiographic-gated multiphasic thinslice cardiac CT examinations were performed to evaluate the MV anatomy. Analysis was done on short-axis images of the mitral annulus. Visual analysis of the circumferential extent and density of calcifications was performed (Fig. 1 ). Patients were required to have either complete circumferential annular calcification or continuous calcification of greater than three-fourth of the mitral annulus including the entire posterior annulus and past both commissures into the anterior annulus. The mitral annular area was measured by tracing the entire calcium bar border on the short-axis views ( Fig. 2A ) in end-diastole phase. Valve sizing was estimated based on oversizing the mitral annular area measured on CT scan, with the exception of the earliest case performed where sizing was done intraoperatively. Measurement of the aortomitral angle on CT scan was done in the systolic phase to assess the risk of LVOT obstruction (Fig. 2B ). An angle of 120 was considered high risk for LVOT obstruction as described previously [5] . Doppler echocardiography was used for assessing baseline LVOT gradient and transmitral diastolic gradient. Patients included in this study were deemed to be at high risk for developing haemodynamically significant LVOT obstruction using the transfemoral or transapical approach for transcatheter MVR.
The procedures were performed in the operating room at Mayo Clinic. Procedures were done under general anaesthesia. Access to the thoracic cavity was performed by a cardiac surgeon via either a median sternotomy (n = 3) or right anterolateral thoracotomy (n = 3). Normothermic cardiopulmonary bypass was initiated via central or femoral cannulation. The procedure was performed using on-pump beating-heart technique with no cardioplegic arrest in 4 patients. The MV was approached via a standard left atriotomy in 4 patients and/or via a vertical trans-septal approach in the remaining 2 patients. The MV was visualized, and standard valve replacement was ruled out. If deemed to be at high risk of LVOT obstruction based on direct visualizing and preprocedural imaging, the anterior MV leaflet was resected. A balloonexpandable transcatheter valve was prepared and oriented for antegrade delivery over an extra stiff guide wire placed into the left ventricle. The valve delivery system was placed over the wire and carefully advanced into the native annular position. The transcatheter valve was slowly deployed with 2 extra cubic centimetre of saline in the balloon for oversizing. Post-dilation and anchoring stitches were performed for paravalvular leak (PVL) when deemed necessary. The delivery system was then removed (Fig. 3) .
After valve deployment, the atriotomy was closed in the standard fashion using running polypropylene sutures. The heart was deaired and the patient weaned off cardiopulmonary bypass. The final position, degree of regurgitation, the transmitral gradient and the cardiac function were measured using transoesophageal echocardiogram (Fig. 4) . At the end of the procedure, protamine was given followed by decannulation and closure of all incisions.
RESULTS

Patient characteristics
From December 2014 till May 2016, 6 patients underwent transatrial balloon-expandable valve implantation for severe MAC. Half of the patients were females. The mean age was 81 ± 9 years with an average Society of Thoracic Surgeons risk score of 10.3 ± 6%. Two patients had low Society of Thoracic Surgeons scores but were deemed to have prohibitive anatomy for standard MVR due to exuberant MAC. All patients had multiple comorbidities as summarized in Table 1 . Half of these patients had prior sternotomies and 67% had prior aortic valve replacement. All patients had at least New York Heart Association Class III-IV symptoms significantly limiting their quality of life. The mechanism of heart failure was severe MV stenosis in all patients and concomitant severe MV regurgitation in 1 patient.
Imaging characteristics
All patients were determined to be at high risk of LVOT obstruction post transcatheter MVR. Average mean diastolic gradient across the MV was 14 ± 3 mmHg with an average peak E velocity of 2.3 ± 0.5 m/s. Average indexed left atrial volume was 63 ± 12 cm 3 / m 2 . Average left ventricular ejection fraction was 62 ± 12% with an average right ventricular systolic pressure of 60 ± 13 mmHg. All patients had severe MAC on CT of the chest (Fig. 4) ; 2 of whom had posterior distribution of MAC and the remaining had circumferential distribution of MAC. MV area measured on reconstructed CT scan ranged from 6.3 to 8.6 cm 2 . Average aortomitral angle was 110 ± 11
. Imaging characteristics are summarized in Table 2 .
Procedural outcomes
Three patients had right thoracotomy, while the rest had median sternotomy. MV was exposed by left transatriotomy, while 2 patients had right atriotomy followed by trans-septal access to left atrium due to the presence of extensive adhesions. Four patients had concomitant anterior MV leaflet resection. Valves were deployed under direct visualization in 4 patients; however, later, fluoroscopic imaging ( Fig. 5 ) was used along with direct visualization to guide positioning of the relative to the atrium and ventricle. The valve was successfully deployed in all patients. The diastolic mean gradient across the MV decreased to 5 ± 1 mmHg post deployment and the average right ventricular systolic pressure was 56 ± 16 mmHg. There was no significant LVOT obstruction in the 5 cases that had LVOT gradient measurement. MV periprosthetic regurgitation was severe in 3 patients. Post-dilation was done in 2 patients, and anchoring sutures were placed in 2 other patients. Attempt for sutures failed in 2 other patients, given extensive calcification and friable atrial tissue. Procedural outcomes are summarized in Table 3 .
Follow-up
Within 30 days of follow-up, 3 of the 6 patients died. The first death occurred in a 70-year-old patient with a prior history of radiation to the chest and prior endocarditis with extensive adhesions noted intraoperatively. Access to the patient's left atrium was challenging due to that and was performed through a transseptal access after right atriotomy. The patient had partial valve migration of the valve into the left atrium on postoperative day 3, resulting in severe mitral perioprosthetic regurgitation that was deemed irreparable. The patient's postoperative course was further complicated by septic shock, respiratory failure and multisystem organ failure. The second mortality occurred in a 90-year-old patient who died in the operating room because of cardiogenic shock secondary to irreparable severe PVL due to valve migration towards the left atrium. The third patient who died after 11 postoperative days had severe PVL and cardiogenic shock. The remaining patients were alive at 30 days post procedure. Of the patients who survived, 1 patient required prolonged rehabilitation due to severe deconditioning, and a second patient was readmitted with acute heart failure in the setting of severe mitral paravalvular regurgitation and underwent percutaneous PVL closure.
DISCUSSION
This series of patients undergoing transatrial implantation of balloon-expandable valves in the mitral position for severe MAC demonstrates the challenges inherent to the treatment of patients with symptomatic MV disease with severe MAC; the high rate of PVL after transatrial SAPIEN implantation in severe MAC, which is often severe and difficult to repair and the high rate of morbidity and mortality with this technique. Several lessons were learned in this series including (i) careful valve sizing, and characterization of the MAC based on preprocedural CT angiography is required in particular to minimize risk of valve migration and PVL; (ii) partial anterior leaflet resection is important to minimize the risk of LVOT obstruction, which is not uncommon in published series [6] [7] [8] and (iii) the addition of fluoroscopic guidance to direct visualization offered better positioning of the valve in relation to the atrium and ventricle. Severe MAC presents a daunting therapeutic challenge. Several surgical techniques have been described to handle the hostile mitral annulus but carry significant morbidity, such as atrioventricular disruption, long cardiopulmonary bypass and cross-clamp time, stroke, left atrial wall dissection and injury to the circumflex artery [9] [10] [11] [12] .
Patients with severe MAC are often elderly with multiple comorbidities, making them poor surgical candidates [13] . The success of transcatheter aortic valve replacement has led to an expansion of this application to patients with severe MAC who are at high risk or prohibitive risk for valve surgery [4, [14] [15] [16] . Percutaneous trans-septal delivery has been used for treating severe MAC [17] . This approach has the advantage of avoiding sternotomy, decrease bleeding risk given the venous access and decrease hospital stay [17, 18] . The challenge with this approach includes displacement of the anterior mitral leaflet causing LVOT obstruction, prosthesis stability, perivalvular leak and wire entrapment in the chordae apparatus [6, [17] [18] [19] . Similarly, LVOT obstruction and PVL remain a challenge using described transapical approaches [18, [20] [21] [22] .
Direct transatrial approach in patients with severe MAC has emerged as an option to overcome some of the challenges mentioned [4, 12, 17, 18, [23] [24] [25] [26] [27] . This approach offers the advantage of direct visualization and fluoroscopy of the transcatheter valve implantation for proper ventricular alignment, resection of the anterior leaflet to decrease the risk of LVOT obstruction and possibility of repairing the perivalvular leak at the time of surgery, either by stitching or percutaneous PVL closure devices. This approach also allows a more ventricular implantation that provides a better seal, given the location of the cuff on the transcatheter valve. The transatrial approach may also facilitate MVR in patients with porcelain aorta, which is not an uncommon finding in patients with severe MAC, thus minimizing the dissection required to implant the mitral prosthesis. Although the transatrial approach shows promise, significant challenges still remain. The patients in this series had significant comorbidities, including radiation to the chest, making them high-risk surgical candidates. Prosthesis stability and PVL were the most important technical complications observed because of the extensive degree of calcifications, the non-circular mitral annular anatomy and the difficulty in obtaining a good seal after the deployment of the prosthesis. Severe PVL occurred in 4 patients in our series and was responsible for an intraoperative mortality. One of the possible causes for this was anterior mitral leaflet resection altering the anchoring forces that were predicted support the valve prosthesis based on preprocedural imaging. In this early experience, the use of additional volume added to balloon inflation above the maximal recommended limit (additional 2 mL of volume was added) was conservative, given the concern for annular rupture, which did not occur in our series, and that could have led to underapposition of the prosthesis to the annulus, causing PVL and valve migration. Standard suturing to seal the leak as in standard prosthesis did not work in these cases due to the different design of the prosthesis compared with conventional surgical valves and the extensive degree of calcification in the mitral annulus. Initially, valve deployment was done under direct visualization. The use of fluoroscopic guidance with direct visualization in the hybrid operating room offered better positioning of the valve relative to the MAC, atrium and ventricle. Knowledge of this is important, because the more ventricular the valve position is, the better the anchoring but the higher the risk of LVOT obstruction; while the more atrial, the higher the risk of PVL and the lower the risk of LVOT obstruction.
To improve outcomes, several facets of this technique should be refined. Given the anatomic complexity of such interventions, careful procedural planning is important. In this series, patients were considered to be at high risk for LVOT obstruction based on their calculated aortomitral angle. However, only 4 of the 6 patients had anterior mitral leaflet resection, and none had LVOT obstruction after valve deployment. This reflects the need for better measurements to predict the LVOT obstruction risk. The 3D prototyping of the valve anatomy in patients with severe MAC is a novel technology that shows promise. Using the software and the printed physical models, 3D prototyping has potential uses in procedural simulation as well as in assisting with adequacy of fit and potentially help minimize PVL and enhance valve stability. It can also determine the risk of LVOT obstruction by placing a digital valve and measuring %LVOT obstruction, which is the difference between the native LVOT area and the neo-LVOT area, which is the LVOT area calculated after placing a digital valve, divided by the native LVOT area [12] . Patients with acceptable comorbidities and favourable anatomy will be important for the success of this procedure. Selecting patients with circumferential MAC might offer better valve stability compared to those with only posterior or anterior MAC. In our series, mitral annular areas ranged from 630 to 890 mm 2 , which could have been too large to oversize with current transcatheter valves. Therefore, selecting patients in whom at least 5-10% area oversizing can be achieved with transcatheter valve implantation may also help to minimize PVL and optimize prosthesis anchoring. Moreover, intraoperative balloon sizing could be used for optimal valve sizing, especially after resection of the anterior leaflet, which can alter the preoperative valve sizing measurements. From a technical standpoint, several strategies can be performed to improve outcomes. Visualization and identification of the landing zone can be hindered by the expanding valve during deployment; therefore, using fluoroscopy in the hybrid operating room can help guide better positioning of the valves. This could sometimes be challenging from an ergonomic standpoint for the surgeon if steep fluoroscopic angles are required to be coplanar; in our series, we did not require more than 30 right anterior oblique angulation with no ergonomic difficulties. To lower the risk of PVL, the valves can be deployed with additional volume during balloon inflation (up to 4 additional milliliters) as well as resection of a shorter segment of the anterior mitral leaflet while maintaining a uniform distribution of calcified annulus can be performed. Another technique would be left ventricular septal myectomy to lower LVOT obstruction risk without modifying the anterior leaflet and altering the valve sizing measurements. If PVL occurs after deployment, several strategies can be performed to reduce it. In our series, suture placement was attempted after deployment but was not successful in reducing PVL, given the friable left atrial tissue and the extensive calcification. However, sutures can be placed before device implantation rather than using them as a salvage technique might help reduce PVL, as they can be placed safely and in locations where there is no calcium or friable tissue. These can then be sutured to the cuff of the valve after deployment. 
